GlassScriptPhysician profile
Rachna Garg
NPI 1487629820
$2,644.49
in general payments reported to CMS, 2019-2025
25 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2020: $273 · 2021: $913 · 2022: $472 · 2023: $241 · 2024: $266 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $645.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $514.20 | 2019-2024 | Farxiga, Airsupra, Tezspire |
| Nestle Healthcare Nutrition INC. | $426.01 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $237.40 | 2019-2024 | Ofev |
| Pfizer INC. | $216.45 | 2019-2021 | |
| Glaxosmithkline, LLC. | $197.77 | 2019-2023 | Arexvy, Shingrix, Trelegy Ellipta |
| Mylan Specialty L.P. | $145.49 | 2020-2023 | Yupelri |
| Inspire Medical Systems, INC. | $128.83 | 2024-2025 | Inspire |
| Novo Nordisk INC | $126.89 | 2019-2025 | Ozempic, Rybelsus |
| Regeneron Healthcare Solutions, INC. | $120.12 | 2022-2024 | Dupixent |
| Janssen Pharmaceuticals, INC | $82.79 | 2020-2022 | |
| Philips North America LLC | $77.37 | 2019-2025 | Vest Therapy Und |
| Electromed, INC. | $52.81 | 2021 | |
| Merck Sharp & Dohme LLC | $43.17 | 2023 | |
| Jazz Pharmaceuticals INC. | $39.94 | 2021-2022 | |
| Abbott Laboratories | $34.50 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $31.24 | 2023 | Glassia |
| E.R. Squibb & Sons, L.L.C. | $25.22 | 2019-2021 | |
| Insulet Corporation | $23.59 | 2025 | Omnipod |
| Lucid Diagnostics INC. | $23.09 | 2025 | |
| Phathom Pharmaceuticals, INC. | $21.06 | 2024 | Voquezna |
| Viatris Specialty LLC | $19.42 | 2025 | Yupelri |
| Novartis Pharmaceuticals Corporation | $16.49 | 2019 | |
| Exact Sciences Corporation | $14.87 | 2025 | The Cologuard Plus Collection Kit |
| Baxter Healthcare | $13.61 | 2023 | Hillrom - Life 2000 Ventilation System |
| Advanced Respiratory, INC | $12.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachna Garg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.